Register entry

Meiji Seika Pharma Co., Ltd.

Data as of · How to read this entry

Registered sites
3
Active NDC listings
1
Live patents
0
Countries
1
Base
Japan
Authorisation

Registered operations

Analytical testing3Active ingredient (API) manufacture2Finished drug manufacture1Packaging1
Sites

Registered establishments

3
EstablishmentAddressRegistered forFEI / DUNS
Meiji Seika Pharma Co., Ltd.3-3, Kitakogyodanchi, Kitakami, Iwate 024-0002, Japan (JPN)Analytical testing, Active ingredient (API) manufacture3002902776695400580
Meiji Seika Pharma Co., Ltd.2890, Kitagata, Kitagatacho, Motosu-gun, Gifu 501-0431, Japan (JPN)Analytical testing, Active ingredient (API) manufacture3008927877695400606
Meiji Seika Pharmatech Co., Ltd.Registrant: Meiji Seika Pharma Co., Ltd.1056, Kamonomiya, Odawara, Kanagawa 250-0874, Japan (JPN)Analytical testing, Finished drug manufacture, Packaging3015407855739489196
Catalogue

Marketed products

1
BrandGeneric nameForm / routeNDC
-Doxorubicinpowder12543-3209BULK INGREDIENT
Compare

Comparable companies in Japan

Enquiry

Common questions

Is Meiji Seika Pharma Co., Ltd. FDA approved?
Meiji Seika Pharma Co., Ltd. holds 3 FDA-registered establishments in Japan. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Meiji Seika Pharma Co., Ltd.'s drugs manufactured?
The FDA register lists Kitakami; Motosu-gun; Odawara. Registered operations: analytical testing, active ingredient (API) manufacture, finished drug manufacture, packaging.
What drugs does Meiji Seika Pharma Co., Ltd. make?
1 product is listed under Meiji Seika Pharma Co., Ltd. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.